These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38799499)

  • 21. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention.
    Puigdemont D; Portella M; Pérez-Egea R; Molet J; Gironell A; de Diego-Adeliño J; Martín A; Rodríguez R; Àlvarez E; Artigas F; Pérez V
    J Psychiatry Neurosci; 2015 Jul; 40(4):224-31. PubMed ID: 25652752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Husain MI; Chaudhry IB; Khoso AB; Kiran T; Khan N; Ahmad F; Hodsoll J; Husain MO; Naqvi HA; Nizami AT; Chaudhry N; Khan HA; Minhas F; Meyer JH; Ansari MA; Mulsant BH; Husain N; Young AH
    JAMA Netw Open; 2023 Feb; 6(2):e230147. PubMed ID: 36808239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.
    Farabaugh AH; Bitran S; Witte J; Alpert J; Chuzi S; Clain AJ; Baer L; Fava M; McGrath PJ; Dording C; Mischoulon D; Papakostas GI
    Int Clin Psychopharmacol; 2010 Jul; 25(4):214-7. PubMed ID: 20400905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T3 augmentation of SSRI resistant depression.
    Abraham G; Milev R; Stuart Lawson J
    J Affect Disord; 2006 Apr; 91(2-3):211-5. PubMed ID: 16483669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):291-304. PubMed ID: 21959915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients.
    Rao D; Xu G; Lu Z; Liang H; Lin K; Tang M
    Neuropsychiatr Dis Treat; 2019; 15():3411-3417. PubMed ID: 31849475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
    DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
    BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
    Deligiannidis KM; Meltzer-Brody S; Gunduz-Bruce H; Doherty J; Jonas J; Li S; Sankoh AJ; Silber C; Campbell AD; Werneburg B; Kanes SJ; Lasser R
    JAMA Psychiatry; 2021 Sep; 78(9):951-959. PubMed ID: 34190962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
    Chen MH; Cheng CM; Gueorguieva R; Lin WC; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Krystal JH; Su TP
    Neuropsychopharmacology; 2019 Nov; 44(12):2112-2118. PubMed ID: 31421635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.
    McIntyre RS; Konarski JZ; Mancini DA; Fulton KA; Parikh SV; Grigoriadis S; Grupp LA; Bakish D; Filteau MJ; Gorman C; Nemeroff CB; Kennedy SH
    CMAJ; 2005 Nov; 173(11):1327-34. PubMed ID: 16301700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia.
    Zheng W; He M; Gu LM; Lao GH; Wang DF; Mai JX; Wu HW; Nie S; Huang X
    J Affect Disord; 2022 Aug; 310():223-227. PubMed ID: 35550826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission.
    Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA
    J Affect Disord; 2012 Dec; 142(1-3):77-81. PubMed ID: 22980402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression.
    Liu Y; Hu Q; Xu S; Li W; Liu J; Han L; Mao H; Cai F; Liu Q; Zhu R; Fang C; Lou Y; Wang Z; Yang H; Wang W
    J Affect Disord; 2024 Feb; 347():437-444. PubMed ID: 38000472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression.
    Merkl A; Schneider GH; Schönecker T; Aust S; Kühl KP; Kupsch A; Kühn AA; Bajbouj M
    Exp Neurol; 2013 Nov; 249():160-8. PubMed ID: 24012926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of adjunctive intensive transcranial direct current stimulation of different cortices in treatment-resistant depression: a study protocol for a randomized double-blinded sham-controlled trial.
    Chen Y; Lyu D; Wang F; Huang Q; Yang W; Zhang M; Wei Z; Shi S; Kong S; Chen S; He S; Yang V; Fang Y; Hong W
    BMC Psychiatry; 2022 Dec; 22(1):802. PubMed ID: 36536362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
    Zavaliangos-Petropulu A; McClintock SM; Khalil J; Joshi SH; Taraku B; Al-Sharif NB; Espinoza RT; Narr KL
    J Affect Disord; 2023 Jul; 333():161-171. PubMed ID: 37060953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.